This cohort study examines patient data from January 2019 to December 2023 to evaluate national trends in the use of artificial intelligence–based screenings to detect diabetic retinopathy among patients with types 1 or 2 diabetes.
Visionary News & Insightful Strategy
Footer
A RETINA-SPECIFIC ORGANIZATION
It’s clearly an advantage to work with a consulting group that’s focused on your industry. The team at Retina Consultant has over 50 years of retina-specific experience in healthcare business, practice management, marketing & operations.
We’ve got our eyes on working with the best retina groups and vendors in the industry.
See the best; get in touch.
Recent
- Retina specialist recommends targeted approach to diagnosing uveitis
- Proper credentialing, emergency protocols key for mitigating anesthesia negligence claims
- Ophthalmic community must collaborate to mitigate malpractice risk in use of AI
- Clear patient instructions key to success for Jones tube placement
- InflammX Therapeutics enters option agreement with Bausch + Lomb, grants right to acquire the company
Leave a Reply